IL-6 is an independent predictive factor of drug survival after dose escalation of infliximab in patients with rheumatoid arthritis

Koji Takasugi, Keiichiro Nishida, Masamitsu Natsumeda, Misuzu Yamashita, Wataru Yamamoto, Kazuhiko Ezawa

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'IL-6 is an independent predictive factor of drug survival after dose escalation of infliximab in patients with rheumatoid arthritis'. Together they form a unique fingerprint.

Medicine & Life Sciences